Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
03/03/2004 | EP1392296A1 Thiazolidinediones alone or in conbination with other therapeutic agents for inhibiting or reducing tumour growth |
03/03/2004 | EP1392291A2 Tripeptidyl peptidase inhibitors |
03/03/2004 | EP1392280A2 Arylsulfonamide ethers, and methods of use thereof |
03/03/2004 | EP1307460B1 METHOD FOR THE PRODUCTION OF IMIDAZO-[1,2-c][2,3]-BENZODIAZEPINES AND INTERMEDIATES IN THE PRODUCTION THEREOF |
03/03/2004 | EP1210345B1 Oxazole ppar antagonists |
03/03/2004 | EP1045839B1 Novel amines as pharmaceutical agents |
03/03/2004 | EP1038874B1 Oxime derivatives and agricultural chemicals containing the same |
03/03/2004 | EP0882714B1 Substituted vinylpyridine derivatives and drugs containing the same |
03/03/2004 | EP0853617B1 Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
03/03/2004 | CN1479728A Pexoxisome proliferator activated receptor alpha agonists |
03/03/2004 | CN1479618A Treatment of sexual dysfunction using boonbesin antagonist |
03/03/2004 | CN1478778A 抗真菌剂及其制备方法和中间体 Antifungal agent and its preparation method and intermediates |
03/03/2004 | CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor |
03/03/2004 | CN1140513C Phenylsulphenyl ureas, process for their preparation and their use as herbicides and plant-growth regulators |
03/02/2004 | US6699895 2-aminothiazoline derivatives and process for preparing the same |
03/02/2004 | US6699879 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists |
03/02/2004 | US6699870 Phthalazine compounds and therapeutic agents for erectile dysfunction |
03/02/2004 | US6699867 4-(4-Methyl-piperazin-1-ylmethyl)-4,5-dihydrothiazol-2-ylamine |
03/02/2004 | US6699866 For therapy of addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, alzheimer's disease, obesity, emesis, psychosis, analgesia, schizophrenia, parkinson's disease, restless leg syndrome, sleeping disorders |
03/02/2004 | US6699865 Protein kinase inhibitors, for treating cancer inflammatory disorders, restenosis, and cardiovascular disease. |
03/02/2004 | US6699860 Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists |
03/02/2004 | US6699857 Tetrahydroquinolinyl 6-methyldihydrothiadiazinone derivatives and use thereof |
03/02/2004 | US6699856 Pyrazinones, compositions containing such compounds and methods of use |
03/02/2004 | US6699854 2-substituted 4-heteroaryl- pyrimidines, inhibitors of cyclin-dependent kinases (cdks) |
03/02/2004 | US6699853 Protecting useful plants against the undesirable action of harmful insects, acarids and nematodes, |
03/02/2004 | US6699818 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides |
03/02/2004 | US6699651 Base precursors for use in a photothermographic element |
03/02/2004 | CA2138289C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
02/26/2004 | WO2004016741A2 Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use |
02/26/2004 | WO2004016622A1 Derivatives of 4-4'-bipyridyl-2-2'-bisoxazoles and 4-4'-bipyridyl-2-2'-bistiazoles as antineoplasic agents |
02/26/2004 | WO2004016604A2 Azabicyclic compounds are central nervous system active agents |
02/26/2004 | WO2004016601A1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
02/26/2004 | WO2004016600A1 Novel use of benzothiazole derivatives |
02/26/2004 | WO2004016592A1 Prenylation inhibitors and methods of their synthesis and use |
02/26/2004 | WO2004016587A1 Nitrogen-containing compounds |
02/26/2004 | WO2003099337A3 Inclusion complexes of rosiglitazone |
02/26/2004 | WO2003099211A3 Mitotic kinesin inhibitors |
02/26/2004 | WO2003062388A3 Inhibition of rna function |
02/26/2004 | WO2003057144A3 Change inhibitors of dipeptidyl peptidase iv |
02/26/2004 | WO2003050261A3 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase |
02/26/2004 | WO2002098424B1 Novel anti-infectives |
02/26/2004 | WO2002088120B1 Method for obtaining pioglitazone as an antidiabetic agent |
02/26/2004 | US20040039038 Biaromatic compound activators of PPARy-type receptors |
02/26/2004 | US20040039037 Heterocyclic compounds and uses thereof |
02/26/2004 | US20040039035 A (Ar1-X-Ar2) compound, where Ar1 and Ar2= aryl, heteroaryl or fused arylheteroaryl, X= secondary or tertiary amine, -C(=O)S, -CH=CHSO2 and -SO2N(R)2, and R=H or alkyl, useful for treating contact hypersensitivity |
02/26/2004 | US20040039033 Administering (1-phenyl-2-heteroaryl)ethyl-guanidine compounds for treating ischemic conditions including myocardial infarction, congestive heart failure, and cardiac arrhythmias |
02/26/2004 | US20040039029 Thiazolyl urea compounds and methods of uses |
02/26/2004 | US20040039026 Macromolecules such as (12R,13S,15S)-cyclopropyl 5-methyl-pyridine epothilone A, used as tubulin polymerization promoters and for cytolysis cancer cells; antiproliferative agents |
02/26/2004 | US20040039016 HIV protease inhibitors |
02/26/2004 | US20040039008 Peroxy compounds such as adamantane-2-spiro-3'-8'-((1'S)-10'-camphorsulfonyl)-1',2',4'-trioxa-8' -azaspiro(4.5)decane, used for prophylaxis of malaria or schistosomiasis infections |
02/26/2004 | US20040038998 Aminopiperidine quinolines and their azaisosteric analogues with antibacterical activity |
02/26/2004 | US20040038992 2-thio-(or oxy)-5-amino-1,3,4-thiadiazoles or oxadiazoles |
02/26/2004 | US20040038990 Aminothiazole derivatives |
02/26/2004 | US20040038987 Novel cyclic diamine compounds and medicine containing the same |
02/26/2004 | US20040038979 Novel 6-heteroarylphenanthridines |
02/26/2004 | US20040038973 Treating osteoarthritis or rheumatoid arthritis |
02/26/2004 | US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc. |
02/26/2004 | US20040038968 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl) thiazolidine-2,4-dione potassium salt |
02/26/2004 | US20040038941 Compounds for the treatment of inflammatory disorders |
02/26/2004 | US20040038858 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours |
02/26/2004 | CA2495589A1 Azabicyclic compounds are central nervous system active agents |
02/26/2004 | CA2495492A1 Novel use of benzothiazole derivatives |
02/25/2004 | EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials |
02/25/2004 | EP1391456A1 2-iminoimidazole derivative (2) |
02/25/2004 | EP1391454A1 Substituted benzamide compounds with antihypertensive activity |
02/25/2004 | EP1391451A1 2-iminopyrrolidine derivates |
02/25/2004 | EP1390363A2 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method |
02/25/2004 | EP1390353A1 Triazole-derived kinase inhibitors and uses thereof |
02/25/2004 | EP1390350A1 Novel compounds |
02/25/2004 | EP1390034A1 N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists |
02/25/2004 | EP1263756B1 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
02/25/2004 | EP1211246B1 Pyrimidine derivatives and herbicides containing the same |
02/25/2004 | EP1042296B1 Substituted isoquinoline derivatives and their use as anticonvulsants |
02/25/2004 | EP1040108B1 Ortho-anthranilamide derivatives as anti-coagulants |
02/25/2004 | EP0981526B1 Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
02/25/2004 | EP0906297B1 1,2,4-benzothiadiazine derivatives, their preparation and use |
02/25/2004 | CN1478084A Compounds useful in treatment of inflammatory diseases |
02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |
02/25/2004 | CN1478075A Chemical process and new intermediates |
02/25/2004 | CN1477960A EPA receptor inhibitors to treat rheumatoid arthritis |
02/25/2004 | CN1477946A Method of repairing or restoring damaged or defective hair |
02/25/2004 | CN1139580C Substituted benzylamines and their use for treatment of depression |
02/25/2004 | CN1139577C Improved process for preparation of unsymmetrical 4,6-bis(aryloxy) pyrimidine compounds |
02/24/2004 | US6696482 Formulations for hydrophobic pharmaceutical agents |
02/24/2004 | US6696473 Heterocyclic modulators of nuclear receptors |
02/24/2004 | US6696469 For treatment of diseases or pathological conditions in which endothelial dysfunction is known; atherosclerosis, dyslipidaemia, diabetes |
02/24/2004 | US6696459 Using high affinity, high selectivity quinoline derivativesw |
02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
02/24/2004 | US6696451 Dihydropyrimidines |
02/24/2004 | US6696437 Polymerase inhibitors comprising heterocyclic amides such as 2-pyridin-2-ylbenzimidazole-4-carboxamide, used for prophylaxis of neurodegenerative disorders, damage to hearts or brains, and as anticarcinogenic agents |
02/19/2004 | WO2004015131A2 Hepatitis c virus assays |
02/19/2004 | WO2004014919A1 Epothilone derivatives |
02/19/2004 | WO2004014915A1 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
02/19/2004 | WO2004014904A1 Antiproliferative 2-(heteroaryl)-aminothiazole compounds, pharmaceutical compositions and methods for their use |
02/19/2004 | WO2004014903A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
02/19/2004 | WO2004014902A2 Compounds having an activity at metabotropic glutamate receptors |
02/19/2004 | WO2004014900A1 Benzimidazoles and benzothiazoles as inhibitors of map kinase |
02/19/2004 | WO2004014885A1 Amino benzothiazole compounds with nos inhibitory activity |
02/19/2004 | WO2004014884A1 Thiazole derivatives |
02/19/2004 | WO2004014881A2 '1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5 |